Lupus-like manifestations after allogenic hematopoietic stem cell transplantation: a rare case of chronic graft-versus-host disease

被引:0
|
作者
Yang, Jing [1 ]
Zhang, Liyin [2 ]
Sha, Wengang [1 ]
Liu, Shaojun [2 ]
Shen, Lei [1 ]
机构
[1] Soochow Univ, Affiliated Hosp 1, Dept Nephrol, 899 Pinghai Rd, Suzhou 215000, Jiangsu, Peoples R China
[2] Shanghai Fudan Univ, Sch Med, Huashan Hosp, Renal Div, Shanghai, Peoples R China
关键词
Graft-versus-host disease; Lupus; Proliferative glomerulonephritis; Crescent; Mycophenolate mofetil; CONSENSUS DEVELOPMENT PROJECT; NEPHROTIC SYNDROME; CLINICAL-TRIALS; RENAL PATHOLOGY; CRITERIA; DIAGNOSIS;
D O I
10.1007/s40620-024-01988-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Chronic graft-versus-host disease (GvHD) is the leading cause of late death in allogenic hematopoietic stem cell transplantation recipients, of which the kidney is a potential target. In this article, we report an extremely rare case of chronic GvHD, characterized by immune complex-mediated diffuse proliferative glomerulonephritis and various autoantibodies detected in the serum; it is the first case of lupus-like chronic GvHD reported to date. The patient responded well to intensive immunosuppressive therapy and reached complete remission. Mycophenolate mofetil was more effective than tacrolimus in this case, suggesting that treatment of kidney diseases associated with chronic GvHD should be based on pathogenesis and pathological patterns.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Regarding chronic graft-versus-host disease in children and adolescents with thalassemia after hematopoietic stem cell transplantation
    Aleksandra Janowiak–Majeranowska
    Alan Majeranowski
    International Journal of Hematology, 2021, 114 : 147 - 148
  • [42] Toll-Like Receptor Gene Polymorphisms Confer Susceptibility to Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation
    Sivula, J.
    Cordova, Z. M.
    Tuimala, J.
    Jaatinen, T.
    Partanen, J.
    Volin, L.
    Turpeinen, H.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2012, 76 (03) : 336 - 341
  • [43] Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.
    Mielcarek, M
    Martin, PJ
    Leisenring, W
    Flowers, MED
    Maloney, D
    Sandmaier, B
    Maris, M
    Storb, R
    BLOOD, 2002, 100 (11) : 175A - 175A
  • [44] Chronic graft-versus-host disease after allogeneic blood stem cell transplantation
    Przepiorka, D
    Anderlini, P
    Saliba, R
    Cleary, K
    Mehra, R
    Khouri, I
    Huh, YO
    Giralt, S
    Braunschweig, I
    van Besien, K
    Champlin, R
    BLOOD, 2001, 98 (06) : 1695 - 1700
  • [45] Surfactant protein D is associated with pulmonary manifestations of chronic graft-versus-host disease following hematopoietic stem cell transplantation
    Krarup, Anne Mols
    Kielsen, Katrine
    Uhlving, Hilde Hylland
    Steffensen, Rudi
    Sorum, Maria Ebbesen
    Nielsen, Kim Gjerum
    Buchvald, Frederik F.
    Sorensen, Grith L.
    Mueller, Klaus Gottlob
    PEDIATRIC PULMONOLOGY, 2024, 59 (04) : 1103 - 1107
  • [46] Ultrasonographic evaluation of gastrointestinal graft-versus-host disease after hematopoietic stem cell transplantation
    Nishida, Mutsumi
    Shigematsu, Akio
    Sato, Megumi
    Kudo, Yusuke
    Omotehara, Satomi
    Horie, Tatsunori
    Iwai, Takahito
    Endo, Tomoyuki
    Iguchi, Akihiro
    Shibuya, Hitoshi
    Hatanaka, Kanako
    Shimizu, Chikara
    Teshima, Takanori
    CLINICAL TRANSPLANTATION, 2015, 29 (08) : 697 - 704
  • [47] Cardiac Effects of Chronic Graft-versus-Host Disease after Stem Cell Transplantation
    Dogan, Ali
    Dogdu, Orhan
    Ozdogru, Ibrahim
    Yarlioglues, Mikail
    Kalay, Nihat
    Inanc, Mehmet Tugrul
    Ardic, Idris
    Celik, Ahmet
    Kaynar, Leylagul
    Kurnaz, Fatih
    Eryol, Namik Kemal
    Kaya, Mehmet Gungor
    TEXAS HEART INSTITUTE JOURNAL, 2013, 40 (04) : 428 - 434
  • [48] Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Nassar, Amr
    Elgohary, Ghada
    Elhassan, Tusneem
    Nurgat, Zubeir
    Mohamed, Said Y.
    Aljurf, Mahmoud
    JOURNAL OF TRANSPLANTATION, 2014, 2014
  • [49] Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Chen, Yi-Bin
    Shah, Nirav N.
    Renteria, Anne S.
    Cutler, Corey
    Jansson, Johan
    Akbari, Mona
    Chen, Chunlin
    Quadri, Syed
    Parfionovas, Andrejus
    Devine, Steven M.
    BLOOD ADVANCES, 2019, 3 (23) : 4136 - 4146
  • [50] Late Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Omer, Aazim K.
    Weisdorf, Daniel J.
    Lazaryan, Aleksandr
    Shanley, Ryan
    Blazar, Bruce R.
    MacMillan, Margaret L.
    Brunstein, Claudio
    Bejanyan, Nelli
    Arora, Mukta
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (05) : 879 - 883